WuXi Discovery Biology Receives “Excellent Partner Award”

We are honored to have received the "Excellent Partner Award" from the Lilly China Research and Development Center (LCRDC) in March 2014.  The award recognizes of the contribution of the WuXi...

WuXi Corporate Venture Fund Invests in TruTag Security Platform for Drug Safety

We are delighted to announce that WuXi Corporate Venture Fund has made an investment in TruTag.  In addition, WuXi and TruTag will explore collaborations to offer WuXi’s global customers the TruTag...

WuXi Webinar on Neuroscience R&D Drew Over 400 Registrations

Thanks to our elite roster of speakers and participation from both industry and academia, WuXi’s webinar “A New Resurgence of Neuroscience R&D” was a fruitful discussion with a very interactive exchange...

WuXi Partners with Pacific Biomarkers

We are pleased to announce a biomarker collaboration with Pacific Biomarkers (PBI), a premier biomarker laboratory services provider based in Seattle. Biomarkers are a new and important tool in the development of...

WuXi Genome Center Purchases an Illumina HiSeq X Ten Sequencing System

WuXi is pleased to announce that we have purchased an Illumina HiSeq X Ten sequencing system for the WuXi Genome Center.  This new investment will enhance WuXi’s clinical genomic services from...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Game Changer: How Genomics and Technology are Transforming Clinical Trials

Advances in genomics are improving elements of drug development, such as design of clinical trial protocols, enrollment of patients and measurement of a potential...